BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 6281297)

  • 1. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
    J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B; Deuss U; Kaulen D; Leonhardt U; Kallabis D; Hamel E; Winkelmann W
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of low-dose naloxone infusion on plasma ACTH and LH in patients with Cushing's and Addison's diseases.
    Moreira AC; Foss MC; Iazigi N; Verissimo JM
    Horm Metab Res; 1988 Apr; 20(4):230-4. PubMed ID: 2840381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma pituitary hormone responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases.
    Demura R; Suda T; Wakabayashi I; Yoshimura M; Jibiki K; Odagiri E; Demura H; Shizume K
    J Clin Endocrinol Metab; 1981 Feb; 52(2):263-6. PubMed ID: 7462391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naloxone and an enkephalin analog on serum prolactin, cortisol, and gonadotropins in the chimpanzee.
    Gosselin RE; Blankstein J; Dent DW; Hobson WC; Fuller GB; Reyes FI; Winter JS; Faiman C
    Endocrinology; 1983 Jun; 112(6):2168-73. PubMed ID: 6406210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
    Colombo P; Passini E; Re T; Faglia G; Ambrosi B
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine effect of a methionine-enkephalin derivative (FK 33-824) in man.
    del Pozo E; von Graffenried B; Brownell J; Derrer F; Marbach P
    Horm Res; 1980; 13(2):90-7. PubMed ID: 6262206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multihormonal response to corticotropin-releasing hormone in inferior petrosal sinus blood of patients with Cushing's disease.
    Allolio B; Günther RW; Benker G; Reinwein D; Winkelmann W; Schulte HM
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1195-201. PubMed ID: 1699962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A met-enkephalin analog inhibits adrenocorticotropin secretion by cultured pituitary cells from a patient with Nelson's syndrome.
    Lamberts SW; Oosterom R; Verleun T; Bons EG; Uitterlinden P
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1084-6. PubMed ID: 6270182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of a met-enkephalin analogue on ACTH, beta-LPH, beta-endorphin and MET-enkephalin in patients with adrenocortical disease.
    Gaillard RC; Grossman A; Smith R; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1981 May; 14(5):471-8. PubMed ID: 6273021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma LH, FSH and TSH responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases.
    Demura R; Suda T; Wakabayashi I; Ono M; Jibiki K; Odagiri E; Demura H; Shizume K
    Tohoku J Exp Med; 1982 Jul; 137(3):283-7. PubMed ID: 6810504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
    Ambrosi B; Sala C; Bochicchio D; Colombo P; Gazzano G; Fadin C; Morganti A; Faglia G
    Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease.
    Kuwayama A; Kageyama N; Nakane T; Watanabe M; Kanie N
    J Clin Endocrinol Metab; 1981 Jul; 53(1):165-73. PubMed ID: 6263935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.